Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Antonio Linero-Artiaga und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Química Inorgánica, Universidad de Murcia, and Murcia BioHealth Research Institute (IMIB-Arrixaca), E-30100 Murcia, Spain. Hauptthemen laut MEDLINE: Iridium, Benzimidazoles, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundaci?n S?neca, Ministerio de Ciencia, Innovaci?n y Universidades, European Regional Development Fund.
Abstract (Originalsprache)
This study explores the therapeutic potential of seven bis-cyclometalated Ir(III) complexes (1-7), derived from the 2,2'-(benzothiazolyl)benzimidazole scaffold, as highly promising next-generation photoactivatable agents for type I and type II-guided photodynamic therapy (PDT) in lung and colorectal cancers. Their high phototoxicity in 2D and 3D cancer cell models, achieving IC50 values in the nanomolar region, was closely linked to the generation of singlet oxygen and type I reactive oxygen species (ROS) and the photooxidation of NADH, with complex 4 identified as the strongest ROS inducer and the most photocytotoxic complex. Notably, the iridium complexes proved to maintain their phototoxicity in hypoxic conditions. Using 3D spheroids, complex 4 demonstrated deep tissue penetration sought to overcome PDT limitations in solid tumors. Overall, the synthesized complexes showcase high efficacy and favorable pharmacological profiles, positioning them as promising candidates for the ROS-guided photodynamic treatment of cancers, including those located within hypoxic environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Química Inorgánica, Universidad de Murcia, and Murcia BioHealth Research Institute (IMIB-Arrixaca), E-30100 Murcia, Spain.
- Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61200 Brno, Czech Republic.
- Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, CZ-61200 Brno, Czech Republic.
- Department of Biophysics, Faculty of Science, Palacky University, Slechtitelu 27, CZ-78371 Olomouc, Czech Republic.
- Institut für Anorganische Chemie und Strukturchemie, Heinrich-Heine-Universität Düsseldorf, D-40204 Düsseldorf, Germany.
ORCID-Profile: Antonio Linero-Artiaga, Vojtěch Novohradský, Venancio Rodríguez, Lenka Markova, Jana Kasparkova, José Ruiz, Viktor Brabec
Förderung
- Fundaci?n S?neca
- Ministerio de Ciencia, Innovaci?n y Universidades
- European Regional Development Fund
- Grantov? Agentura Cesk? Republiky
- Universidad de Murcia
Zitieren
APA
Linero-Artiaga, A., Svitelova, M., Novohradský, V., Rodríguez, V., Markova, L., Kasparkova, J., Janiak, C., Ruiz, J., & Brabec, V. (2026). Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03280
Vancouver
Linero-Artiaga A, Svitelova M, Novohradský V, Rodríguez V, Markova L, Kasparkova J, et al. Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03280
BibTeX
@article{LineroArtiaga2026,
author = {Linero-Artiaga, Antonio and Svitelova, Marie and Novohradský, Vojtěch and Rodríguez, Venancio and Markova, Lenka and Kasparkova, Jana and Janiak, Christoph and Ruiz, José and Brabec, Viktor},
title = {Novel 2-(2′-Benzothiazolyl)-benzimidazole-Based Iridium(III) Photocatalysts Exhibit Antiproliferative Effects in 2D and 3D Cancer Cells to Bypass Hypoxia-Induced Resistance},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03280}
}
EUVIMED